40 related articles for article (PubMed ID: 2186820)
1. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates.
Munn DH; Garnick MB; Cheung NK
Blood; 1990 May; 75(10):2042-8. PubMed ID: 2186820
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.
Masucci G; Wersäll P; Ragnhammar P; Mellstedt H
Cancer Immunol Immunother; 1989; 29(4):288-92. PubMed ID: 2665935
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic functions of blood mononuclear cells in patients with colorectal carcinoma treated with mAb 17-1A and granulocyte/macrophage-colony-stimulating factor.
Ragnhammar P; Masucci G; Frödin JE; Hjelm AL; Mellstedt H
Cancer Immunol Immunother; 1992; 35(3):158-64. PubMed ID: 1638551
[TBL] [Abstract][Full Text] [Related]
4. Antimetastatic effect of recombinant human macrophage-colony-stimulating factor against lung and liver metastatic B16 melanoma.
Sakurai T; Yamada M; Simamura S; Motoyoshi K
Cancer Immunol Immunother; 1997 Mar; 44(1):48-54. PubMed ID: 9111584
[TBL] [Abstract][Full Text] [Related]
5. Antibody-independent phagocytosis of tumor cells by human monocyte-derived macrophages cultured in recombinant macrophage colony-stimulating factor.
Munn DH; Cheung NK
Cancer Immunol Immunother; 1995 Jul; 41(1):46-52. PubMed ID: 7641219
[TBL] [Abstract][Full Text] [Related]
6. Macrophage colony-stimulating factor enhances rituximab-dependent cellular cytotoxicity by monocytes.
Shimadoi S; Takami A; Kondo Y; Okumura H; Nakao S
Cancer Sci; 2007 Sep; 98(9):1368-72. PubMed ID: 17640305
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune Pulmonary Alveolar Proteinosis.
McCarthy C; Carey BC; Trapnell BC
Am J Respir Crit Care Med; 2022 May; 205(9):1016-1035. PubMed ID: 35227171
[TBL] [Abstract][Full Text] [Related]
8. Hemogram study of an artificially feeding tree shrew (Tupaia belangeri chinensis).
Feng Y; Xia W; Ji K; Lai Y; Feng Q; Chen H; Huang Z; Yi X; Tang A
Exp Anim; 2020 Jan; 69(1):80-91. PubMed ID: 31527336
[TBL] [Abstract][Full Text] [Related]
9. M-CSF improves protection against bacterial and fungal infections after hematopoietic stem/progenitor cell transplantation.
Kandalla PK; Sarrazin S; Molawi K; Berruyer C; Redelberger D; Favel A; Bordi C; de Bentzmann S; Sieweke MH
J Exp Med; 2016 Oct; 213(11):2269-2279. PubMed ID: 27811055
[TBL] [Abstract][Full Text] [Related]
10. Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.
Perez Horta Z; Goldberg JL; Sondel PM
Immunotherapy; 2016 Sep; 8(9):1097-117. PubMed ID: 27485082
[TBL] [Abstract][Full Text] [Related]
11. Interactions between colon cancer cells and tumor-infiltrated macrophages depending on cancer cell-derived colony stimulating factor 1.
Wang H; Shao Q; Sun J; Ma C; Gao W; Wang Q; Zhao L; Qu X
Oncoimmunology; 2016 Apr; 5(4):e1122157. PubMed ID: 27141406
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of a novel Fc conjugate of macrophage colony-stimulating factor.
Gow DJ; Sauter KA; Pridans C; Moffat L; Sehgal A; Stutchfield BM; Raza S; Beard PM; Tsai YT; Bainbridge G; Boner PL; Fici G; Garcia-Tapia D; Martin RA; Oliphant T; Shelly JA; Tiwari R; Wilson TL; Smith LB; Mabbott NA; Hume DA
Mol Ther; 2014 Sep; 22(9):1580-92. PubMed ID: 24962162
[TBL] [Abstract][Full Text] [Related]
13. Treatment of high-risk neuroblastoma with anti-GD2 antibodies.
Castel V; Segura V; Cañete A
Clin Transl Oncol; 2010 Dec; 12(12):788-93. PubMed ID: 21156409
[TBL] [Abstract][Full Text] [Related]
14. Anti-GD2 antibody therapy for GD2-expressing tumors.
Navid F; Santana VM; Barfield RC
Curr Cancer Drug Targets; 2010 Mar; 10(2):200-9. PubMed ID: 20201786
[TBL] [Abstract][Full Text] [Related]
15. Immune therapies for neuroblastoma.
Navid F; Armstrong M; Barfield RC
Cancer Biol Ther; 2009 May; 8(10):874-82. PubMed ID: 19342881
[TBL] [Abstract][Full Text] [Related]
16. CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression.
Fischer-Smith T; Tedaldi EM; Rappaport J
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):417-21. PubMed ID: 18373432
[TBL] [Abstract][Full Text] [Related]
17. Induced expression and association of the Mona/Gads adapter and Gab3 scaffolding protein during monocyte/macrophage differentiation.
Bourgin C; Bourette RP; Arnaud S; Liu Y; Rohrschneider LR; Mouchiroud G
Mol Cell Biol; 2002 Jun; 22(11):3744-56. PubMed ID: 11997510
[TBL] [Abstract][Full Text] [Related]
18. Expansion of CD14+CD16+ monocytes in critically ill cardiac surgery patients.
Fingerle-Rowson G; Auers J; Kreuzer E; Fraunberger P; Blumenstein M; Ziegler-Heitbrock LH
Inflammation; 1998 Aug; 22(4):367-79. PubMed ID: 9675608
[TBL] [Abstract][Full Text] [Related]
19. Selective depletion of CD14+ CD16+ monocytes by glucocorticoid therapy.
Fingerle-Rowson G; Angstwurm M; Andreesen R; Ziegler-Heitbrock HW
Clin Exp Immunol; 1998 Jun; 112(3):501-6. PubMed ID: 9649222
[TBL] [Abstract][Full Text] [Related]
20. Colony-stimulating factor 1 in the human response to neonatal listeriosis.
Grieg A; Roth P
Infect Immun; 1995 Apr; 63(4):1595-7. PubMed ID: 7890428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
